All treatments
Treatment
Xarelto 20 mg film-coated tablets clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
COmparison of Bleeding Risk between Rivaroxaban and Apixaban for the treatment of acute venous thromboembolism
This study compares two common blood-thinning medicines, Rivaroxaban (Xarelto) and Apixaban (Eliquis), for treating blood clots (venous thromboembolism). Researchers want to see which medicine causes fewer serious bleeding side effects for patients already on these treatments.
For: Acute Venous ThromboembolismIreland - Ongoing, recruitingTherapeutic use (Phase IV)
Rivaroxaban sotorasib interaction study (the ROSIE-study)
This study is looking at how two medicines, sotorasib (LUMYKRAS) and rivaroxaban (Xarelto), interact when taken together. Researchers want to see if taking sotorasib affects how much rivaroxaban stays in your body and for how long. It involves healthy volunteers.
For: Healthy subjectsNetherlands